Zheng FY, Yang KS, Min WC, Li XZ, Xing Y, Wang S, Zhang YS, Zhao QC. Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis. World J Gastrointest Surg 2024; 16(2): 571-584 [PMID: 38463352 DOI: 10.4240/wjgs.v16.i2.571]
Please LOGIN to submit a new comment.